Isthmus Partners LLC Has $1.93 Million Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Isthmus Partners LLC trimmed its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,464 shares of the medical instruments supplier’s stock after selling 598 shares during the period. Isthmus Partners LLC owned about 0.93% of Utah Medical Products worth $1,934,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of UTMD. Golden State Wealth Management LLC bought a new position in shares of Utah Medical Products during the 4th quarter valued at about $31,000. R Squared Ltd acquired a new position in shares of Utah Medical Products in the fourth quarter valued at approximately $49,000. BNP Paribas Financial Markets boosted its holdings in shares of Utah Medical Products by 102.7% in the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after buying an additional 566 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Utah Medical Products during the fourth quarter worth $157,000. Finally, Virtu Financial LLC acquired a new stake in shares of Utah Medical Products during the third quarter worth $207,000. 69.60% of the stock is currently owned by institutional investors.

Utah Medical Products Trading Up 0.7 %

Shares of NASDAQ UTMD opened at $58.72 on Monday. The company has a fifty day moving average price of $60.93 and a 200 day moving average price of $63.86. The firm has a market cap of $199.18 million, a PE ratio of 14.87 and a beta of 0.06. Utah Medical Products, Inc. has a 1-year low of $58.05 and a 1-year high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings data on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th will be given a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date is Friday, March 14th. Utah Medical Products’s dividend payout ratio is presently 30.89%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.